Link to this page
Physician Data Query
Last uploaded:
August 28, 2024
Jump to:
| Preferred Name | bupropion hydrochloride controlled-release | |
| Synonyms |
Forfivo XL Wellbutrin SR Aplenzin Wellbutrin XL Zyban bupropion HCl controlled-release |
|
| Definitions |
A controlled-release tablet formulation containing the hydrochloride salt of the aminoketone bupropion, with antidepressant activity and for potential use in promoting smoking cessation and improving sexual desire. Bupropion is a weak blocker of the neuronal uptake of serotonin, dopamine and norepinephrine and is a central nicotinic acetylcholine receptor antagonist. The controlled-release formulation results in a higher concentration of the drug in the body over an extended period of time, thereby permitting a reduction in the frequency of dosing |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000792878 |
|
| altLabel |
Forfivo XL Wellbutrin SR Aplenzin Wellbutrin XL Zyban bupropion HCl controlled-release
|
|
| cui |
C4724944 C2609728 C0751626 C0724393 C3272321 C1330606
|
|
| DATE FIRST PUBLISHED |
2018-04-09
|
|
| Date last modified |
2018-04-09
|
|
| definition |
A controlled-release tablet formulation containing the hydrochloride salt of the aminoketone bupropion, with antidepressant activity and for potential use in promoting smoking cessation and improving sexual desire. Bupropion is a weak blocker of the neuronal uptake of serotonin, dopamine and norepinephrine and is a central nicotinic acetylcholine receptor antagonist. The controlled-release formulation results in a higher concentration of the drug in the body over an extended period of time, thereby permitting a reduction in the frequency of dosing
|
|
| LT |
TRD
|
|
| notation |
CDR0000792878
|
|
| ORIG STY |
Drug/agent
|
|
| prefLabel |
bupropion hydrochloride controlled-release
|
|
| tui |
T109 T121
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |